Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wasmuth

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Hepatology (Baltimore, Md.)|January 13, 2012
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in miceHacer Sahin, Erawan Borkham-Kamphorst, Christoph Kuppe, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Hepatology (Baltimore, Md.)|December 10, 2009
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesFlorian van Bömmel, Robert A de Man, Heiner Wedemeyer, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Hepatology (Baltimore, Md.)|January 13, 2012
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in miceHacer Sahin, Erawan Borkham-Kamphorst, Christoph Kuppe, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Hepatology (Baltimore, Md.)|December 10, 2009
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesFlorian van Bömmel, Robert A de Man, Heiner Wedemeyer, et al.
Pageof 11